Alvotech (ALVO) Total Current Liabilities (2020 - 2026)
Alvotech (ALVO) posted Total Current Liabilities of $259.8 million for Q1 2026, down 14.57% on a QoQ basis from $304.1 million in Q4 2025, and down 2.27% year-over-year from $265.8 million in Q1 2025.
Alvotech (ALVO) Total Current Liabilities (2020 - 2026) Analysis & Trends
Alvotech's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $259.8 million for Q1 2026.
- Quarterly Total Current Liabilities fell 2.27% year-over-year to $259.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $259.8 million (down 2.27% YoY) and the FY2025 annual result came in at $304.1 million, up 57.23% from the prior year.
- Total Current Liabilities was $259.8 million for Q1 2026 at Alvotech, down from $304.1 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $1.2 billion in Q2 2024 and bottomed at $160.3 million in Q1 2023.
- A 5-year average of $307.5 million and a median of $260.4 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2024 — Total Current Liabilities surged 442.4% — and 2025, when it slumped 76.74%.
- Alvotech's Total Current Liabilities stood at $167.3 million in 2022, then soared by 55.98% to $261.0 million in 2023, then fell by 25.89% to $193.4 million in 2024, then soared by 57.23% to $304.1 million in 2025, then fell by 14.57% to $259.8 million in 2026.
- Business Quant data shows ALVO's Total Current Liabilities at $259.8 million in Q1 2026, $304.1 million in Q4 2025, and $304.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.56 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.53 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 18.06 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 599.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 6.81 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 831.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.66 Bn |
| 10 | Alvotech | 935.87 Mn | 935.87 Mn | 5.09 Mn | 259.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 259.78 Mn |
| Dec 31, 2025 | 304.08 Mn |
| Sep 30, 2025 | 304.07 Mn |
| Jun 30, 2025 | 279.75 Mn |
| Mar 31, 2025 | 265.81 Mn |
| Dec 31, 2024 | 193.40 Mn |
| Sep 30, 2024 | 160.55 Mn |
| Jun 30, 2024 | 1.20 Bn |
| Mar 31, 2024 | 246.79 Mn |
| Dec 31, 2023 | 260.95 Mn |
| Jun 30, 2023 | 221.69 Mn |
| Mar 31, 2023 | 160.33 Mn |
| Dec 31, 2022 | 167.29 Mn |
| Jun 30, 2022 | 277.79 Mn |
| Dec 31, 2021 | 111.84 Mn |
| Dec 31, 2020 | 50.98 Mn |